Stay updated on G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision label updates from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study record page now shows a 403 Forbidden error page. The page chrome remains visible, but access to the content is blocked.SummaryDifference0.5%

- Check35 days agoChange DetectedAccess to the study record is now blocked by a 403 Forbidden page, preventing display of the trial's details. The page shows a standard 403 layout with navigation and footer intact.SummaryDifference19%

- Check56 days agoChange DetectedAdded a funding note '2017 ( U.S. NIH Grant/Contract )' under the study identifiers and updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a newer page revision. This is a metadata update rather than a substantive change to the study information.SummaryDifference0.0%

Stay in the know with updates to G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.